In this article, we will discuss some of the basic regulatory steps for obtaining reimbursement-approval for medical devices, and list the key impacts and strategic considerations when dealing with HC reimbursement in China.
Home > healthcare reforms
China has one of the largest medtech markets in the world, presenting a market full of opportunities and growth potential now and in the years to come. In this article, we will highlight the medtech market figures of China, in comparison to other leading nations, and pinpoint the Chinese market context and its key drivers.
It has been told sufficiently that the old way of launching and selling a product is no longer the standard approach. Physicians are no longer the deciding factor, at least not in most of the European countries. In a country like Germany, physicians and surgeons still have influence in some situations, in the sense of […]
Healthcare spending in 2015 in Finland was equal to 9.8% of GDP. This reflects an increasing trend over the past 5 years. In absolute terms, healthcare expenditure is equal to €20.3 bn, and €3,704 per capita. Though expenditure is in the lower ranges of the EU average expenditure (in terms of % of GDP), infant […]
In the first article of this series we looked at the organization of the hospital system which is stretched to the limit due to an aging population and an extremely well organized democratic healthcare system that focuses heavily on elderly care. In this second part, the medical devices market is explained and the impact of […]
The Healthcare System in the United States of America: the 2016 Presidential Candidates’ Healthcare Plans – PART 3/3
On October 8th later this year, the 58th presidential elections will be held. This final article in a series of three will have a look at the different propositions and ideas voiced by the current leading candidates regarding their approaches and management plans for the US healthcare system during their presidential term. The highlights of […]
The United States has a GDP of €14,840 bn, with a GDP growth rate of 2.4% in 2015. Over the last 5 years it has spent an average of €7,600 per capita on public healthcare, equivalent to approximately 17% of its annual GDP. Despite being one of the highest spenders on healthcare in the world, […]
Due to the one-child policy in the last 30 years, a growing share of China’s population will soon be over the age of 60, closely aligning its demographic dynamics with those of many developed countries. The Chinese government has made a priority of developing the healthcare sector as well, especially in regards to investing into […]
The Association of Southeast Asian Nations (ASEAN) aims to have the ASEAN Economic Community (AEC) regulated and fully operational by the end of 2015. This blog post looks at the characteristics of the regional healthcare market standards and the impact of the regulation on the Thai Healthcare market.
2015 is proving to be a progressive year in terms of economic growth for Thailand, with a rate of annual GDP growth close to 4%. This is a substantial increase from the previous two-year dip averaging around 1.8%, and is forecasted to remain stable in the coming two years.